Hims & Hers to partner with Novo Nordisk and stop selling compounded GLP-1s

Telehealth institution and Hims & Hers connected Monday announced a “strategic shift” successful its concern model, partnering with pharmaceutical institution Novo Nordisk to merchantability its blockbuster GLP-1 medicine and halt selling the “copycat” compounded versions it has agelong advertised. In a property release, Hims & Hers said it volition “no longer advertise compounded GLP-1 offerings…